Market Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific Receives FDA And CE Mark Approval For New CoverEdge™ Surgical Leads For The Precision Spectra™ Spinal Cord Stimulator (SCS) System

[PR Newswire] – MARLBOROUGH, Mass., Oct. 21, 2014 /PRNewswire/ — Boston Scientific Corporation (BSX) has received U.S. Food and Drug Administration (FDA) and CE Mark approval for the CoverEdge™ 32 and CoverEdge™ X . . . → Read More: Market Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific Receives FDA And CE Mark Approval For New CoverEdge™ Surgical Leads For The Precision Spectra™ Spinal Cord Stimulator (SCS) System Similar Articles: Company Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging Market Update (NYSE:BSX): Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System Stock Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.